GGrantIndex
Sort

10,829 grants matching car t

Promoting post-treatment self-management among Latinos with cancer

$172,369
Anna Maria Napoles · University Of California, San Francisco · R21 · FY2015 · CA

mHealth intervention for ART adherence and sexual risk reduction among HIV+ YMSM

$172,292
Nadia L Dowshen · Children'S Hosp Of Philadelphia · K23 · FY2014 · MH

Transporting treatment effects from clinical trials to real-world populations with co-occurring opioid and stimulant use disorders

$172,285
Ryan Cook · Oregon Health & Science University · K01 · FY2022 · DA

CRII: SaTC: Securing Internet of Things Against Cache-based Attacks

$172,235
Ziming Zhao · Suny At Buffalo · · FY2020 · CSE

CRII: SaTC: Securing Internet of Things Against Cache-based Attacks

$172,235
Ziming Zhao · Rochester Institute Of Tech · · FY2020 · CSE

Sequencing and Viral Evolution Core

$172,193
Frederic D Bushman · University Of Pennsylvania · U19 · FY2015 · AI

Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL

$172,190
Lisa Madalen Niswander · Roswell Park Cancer Institute Corp · K08 · FY2024 · CA

Tasquinimod as an adjunct to immunotherapies administered peri-operatively

$172,185
Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2022 · CA

Innovative Smartphone Application for Quitting Smoking among Seriously Mentally I

$172,179
Roger Vilardaga · University Of Washington · K99 · FY2014 · DA

Measuring Real-Time Influences of Mental and Tangible Resources on Men's TB Treatment Lapses and Adherence Behaviors

$172,079
Andrew Medina-Marino · Desmond Tutu Hiv Foundation · R21 · FY2021 · AI

Biomaterial Scaffolds for In Vivo CAR T Cell Manufacture

$172,076
Yevgeny Brudno · North Carolina State University Raleigh · R21 · FY2023 · CA

STEM CELL THERAPY FOR ACUTE KIDNEY INJURY

$172,066
Fangming Lin · Columbia University Health Sciences · R01 · FY2010 · DK

Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease

$172,013
Maureen Megan O'Brien · University Of Colorado Denver · R50 · FY2024 · CA

Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease

$172,013
Maureen Megan O'Brien · University Of Colorado Denver · R50 · FY2025 · CA

Satellite and geospatial dynamic modeling of malaria risk

$171,985
Tatiana V Loboda · University Of Maryland Baltimore · U19 · FY2017 · AI

Stanford Cancer Institute

$171,975
Steven E Artandi · Stanford University · P30 · FY2024 · CA

Preclinical development and clinical monitoring of adoptive immune therapy

$171,965
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Mobile health interventions for varenicline adherence among HIV-positive smokers

$171,937
Lauren Renee Pacek · Duke University · K01 · FY2021 · DA

Mobile health interventions for varenicline adherence among HIV-positive smokers

$171,937
Lauren Renee Pacek · Duke University · K01 · FY2019 · DA

Mobile health interventions for varenicline adherence among HIV-positive smokers

$171,937
Lauren Renee Pacek · Duke University · K01 · FY2020 · DA

Mobile health interventions for varenicline adherence among HIV-positive smokers

$171,937
Lauren Renee Pacek · Duke University · K01 · FY2017 · DA

JHU-IKU Mobile Health for Child Injury Prevention in Malaysia (M-CHILD)

$171,900
Adnan A Hyder · Johns Hopkins University · R21 · FY2015 · TW

Integrated Digital Health Intervention to Promote Engagement in and Adherence to Medication-Assisted Treatment

$171,729
Kirsten Johnson Langdon · Rhode Island Hospital · K23 · FY2022 · DA

Optimization of adoptive immunotherapy with autologous CD20-specific T cells

$171,720
Brian Till · Fred Hutchinson Cancer Research Center · K23 · FY2015 · CA

Optimization of adoptive immunotherapy with autologous CD20-specific T cells

$171,720
Brian Till · Fred Hutchinson Cancer Research Center · K23 · FY2014 · CA